Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial.

[1]  M. Decramer,et al.  Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[2]  B. Celli,et al.  Sex differences in mortality in patients with COPD , 2009, European Respiratory Journal.

[3]  P. Calverley,et al.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.

[4]  Liam Ck.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008 .

[5]  M. Decramer,et al.  Bronchodilator responsiveness in patients with COPD , 2008, European Respiratory Journal.

[6]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[7]  Susan Murray,et al.  Sex differences in severe pulmonary emphysema. , 2007, American journal of respiratory and critical care medicine.

[8]  Raúl San José Estépar,et al.  Gender differences in the severity of CT emphysema in COPD. , 2007, Chest.

[9]  D. Postma,et al.  A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. , 2007, Chest.

[10]  D. Postma,et al.  Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. , 2006, Respiratory research.

[11]  J. D. de Torres,et al.  Gender and Chronic Obstructive Pulmonary Disease in High-Risk Smokers , 2006, Respiration.

[12]  Don D. Sin,et al.  Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis , 2006, Respiratory research.

[13]  M. Miravitlles,et al.  Problemas con el diagnstico de la EPOC en atencin primaria , 2006 .

[14]  M. Miravitlles,et al.  [Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. , 2006, Archivos de bronconeumologia.

[15]  D. Postma,et al.  Gender differences in the management and experience of Chronic Obstructive Pulmonary Disease. , 2004, Respiratory medicine.

[16]  R. Pauwels,et al.  Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. , 2004, Respiratory medicine.

[17]  M. Decramer,et al.  Clinical Trial Design Considerations in Assessing Long‐Term Functional Impacts of Tiotropium in COPD: The Uplift Trial , 2004, COPD.

[18]  W. Bailey,et al.  Changes in smoking status affect women more than men: results of the Lung Health Study. , 2003, American journal of epidemiology.

[19]  D. Mannino,et al.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Respiratory care.

[20]  D. Tashkin,et al.  Gender bias in the diagnosis of COPD. , 2001, Chest.

[21]  J. Zieliński,et al.  Early detection of COPD in a high-risk population using spirometric screening. , 2001, Chest.

[22]  K. Perkins.  Smoking Cessation in Women , 2001, CNS drugs.

[23]  W. Rejeski,et al.  Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. , 2001, Chest.

[24]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[25]  N. Pride,et al.  Recent trends in physician diagnosed COPD in women and men in the UK , 2000, Thorax.

[26]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[27]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[28]  A. Buist,et al.  Gender differences in smoking cessation after 3 years in the Lung Health Study. , 1995, American journal of public health.

[29]  A. Buist,et al.  Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. , 1994, American journal of respiratory and critical care medicine.

[30]  A. Buist,et al.  The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.

[31]  D. Dockery,et al.  Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. , 1992, The American review of respiratory disease.

[32]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[33]  S. Horne,et al.  Increased susceptibility to lung dysfunction in female smokers. , 1991, The American review of respiratory disease.

[34]  T. Louis,et al.  Cumulative and reversible effects of lifetime smoking on simple tests of lung function in adults. , 1988, The American review of respiratory disease.